The three-dimensional organization of the genome inside the nucleus impacts on key aspects of genome function, including transcription, DNA replication and repair. The chromosome maintenance complex cohesin and the DNA binding protein CTCF cooperate to drive the formation of self-interacting topological domains. This facilitates transcriptional regulation via enhancer-promoter interactions, controls the distribution and release of torsional strain, and affects the frequency with which particular translocations arise, based on the spatial proximity of translocation partners. Here we discuss recent insights into the mechanisms of three-dimensional genome organization, their relationship to haematopoietic differentiation and malignant transformation.
INTRODUCTION
It has long been known that chromatin state is important for haematopoietic malignancies: Chromatin modifiers such as DNA methyl-transferases and demethylases of the ten eleven translocation family are frequently mutated in leukaemia [1, 2] . The genome is organized within three dimensions according to chromatin state. Technical and conceptual advances have enabled unprecedented progress in our understanding of nuclear organization, the factors that organize the genome, and the functional impact of genome organization on essential genome functions such as gene expression, DNA replication and repair [3 && ,4-6,7 & ]. It may therefore not be entirely surprising if factors that contribute to genome organization have joined the ranks of genes that are recurrently mutated in haematopoietic malignancies.
THREE-DIMENSIONAL ORGANIZATION OF THE GENOME
Regulation of gene transcription requires physical contact between gene promoters and enhancers, which are often located far away in the linear sequence of the genome. The spatial organization of the genome can position genes and enhancers in close proximity in three-dimensional nuclear space [3 && ,4,5] (Fig. 1a) . Active and silent regions of the genome assume separate locations in the nucleus. Imaging approaches show that gene-rich chromosomes localize to the centre of the nucleus, gene poor chromosomes to the periphery [8] . Zooming in, biochemical analysis by chromosome conformation capture (3C) and related genome-wide Hi-C approaches [9, 10] show that transcriptionally active chromosomal regions segregate from transcriptionally inert or repressed regions. This allows the formation of chromosomal compartments: A for active and B for inactive or repressed [10] .
Cohesin and the DNA binding protein CTCFalso known as CCCTC-binding factor -cooperate in three-dimensional genome organization by forming self-interacting domains known as topologically associating domains (TADs) and sub-TADs/contact domains in interphase [11] [12] [13] . They are bounded by convergent CTCF sites and their formation depends on cohesin [3 && ,4,14,15] . Current 'loop extrusion' models propose that cohesin extrudes chromatin loops until it encounters the N-terminus of CTCF bound in a convergent, or inward-facing, orientation [6, 16, 17] .
Self-organization according to chromatin state and active TAD formation by CTCF and cohesin can either synergize or antagonize each other. Their interplay depends on the relationship between chromatin modifications and the position of convergent CTCF sites that define the boundaries of TADs: if transitions between active and repressed chromatin coincide with CTCF binding, then TAD formation will synergize with the self-organization of chromatin because TAD formation will contribute to the segregation of active chromatin on one side of the CTCF-imposed boundary from repressed chromatin on the other side of the CTCF-imposed boundary [ 
THREE-DIMENSIONAL GENOME ORGANIZATION AND TRANSCRIPTION IN HAEMATOPOIESIS AND LYMPHOCYTE DEVELOPMENT
The control of gene expression exerted by cohesin and CTCF is important for haematopoietic differentiation. Chromosome compartments reflect chromatin states, and therefore change during differentiation. However, CTCF-binding sites and domains are relatively stable across cell types and during differentiation [13, [18] [19] [20] . In this way, CTCF provides a framework for cell-type-specific factors to specify enhancer -promoter interactions during differentiation. CTCF is required for maintenance of an undifferentiated megakaryocytic state [21] , and for preventing premature plasma cell differentiation in the germinal centre [22] . In erythrocytes, in which transcription of globin genes is developmentally coordinated, interactions between enhancers and globin gene promoters occur within CTCFinsulated subdomains [23, 24] . In thymocyte development, transcription of an non-coding RNA enables CTCF and cohesin-dependent looping to activate Bcl11b, allowing normal progression from the DN2a to the DN2b cell stage [25] . Binding of chromatin organizer proteins regulates transcription and three-dimensional topology of lymphocyte receptor loci [26, 27] .
During monocyte to macrophage differentiation, CTCF binding is a hallmark of stable domains, whereas de novo gained interactions are preferentially marked by activator protein 1 (AP-1) binding [28 & ]. Similarly, de novo interactions in stem cell to neural progenitor differentiation are enriched in YY1 instead of CTCF [29] and Klf4 predominates in gained interactions in epidermal differentiation [30] . These observations support the idea that CTCF is at the basis of constitutive, structural domains, but cell-type-specific transcription factors drive formation of new interactions during differentiation.
Cohesin mutations cause impaired differentiation in leukaemia
Cohesin mutations are frequent in cancer, and in particular in myeloid malignancies including including primary and secondary acute myeloid leukaemia (AML), Down syndrome acute megakaryoblastic leukaemia, myelodysplastic syndrome,
KEY POINTS
Gene regulatory events that drive haematopoiesis occur within a framework of CTCF-based chromatin domains, and the acquisition of new chromatin contacts is facilitated by cell-type-specific factors.
Reduced cohesin function impairs the differentiation of haematopoietic progenitors, and cohesin mutations are frequently found in myeloid malignancies.
Release of DNA torsional stress at domain boundaries by type II topoisomerase can generate DNA damage after chemotherapy and lead to secondary leukaemia.
myeloproliferative neoplasms, chronic myelomonocytic leukaemia and chronic myelogenous leukaemia (CML) [31] [32] [33] [34] . The initial thinking was that reduced cohesin function would promote genomic instability due to defective chromosome segregation [35] . Reduced cohesin function can indeed synergize with the loss of p53 in promoting aggressive T-cell and B-cell lymphomas and leukaemia in mice through increased aneuploidy and accumulation of multiple chromosomal aberrations [36] . However, it is now clear that the majority of cohesin mutations in cancer interfere with cohesin function only moderately [31, 37, 38] . As a result, leukaemic cells retain enough cohesin to meet the requirements for cell cycle progression. This is consistent with observations in model organisms in which the level of cohesin expression is higher than needed for sister chromatid cohesion [39] . 
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Very low levels of cohesin are incompatible with proliferation of stem cells, activating DNA damage checkpoints and triggering replication stress [40, 41] . Importantly however, moderately reduced cohesin function in haematopoietic stem cells can increase self-renewal capacity both in vitro and in vivo [42-44,45 & ,46] . Mouse models of cohesin deficiency present altered composition of the haematopoietic stem cell compartment and skewing of progenitors towards the myeloid lineage [42, 43] . Human cord blood cells that express dominant negative mutant forms of cohesin show impaired responses to differentiation-promoting cytokines and increased frequencies of CD34þ progenitor cells [44] .
Human cord blood progenitor cells with reduced cohesin function show a general decrease in chromatin accessibility [44] . At a subset of binding sites for the transcription factors GATA2 and RUNX1, however, accessibility is increased, and stem cell transcriptional programmes are upregulated [43, 44] . Mechanistically, increased selfrenewal has been attributed to the induction of HoxA9, a transcription factor that promotes the self-renewal of progenitors [45 & ]. In contrast to human progenitor cells, cohesin knock-down in mouse haematopoietic stem cells results in a gene expression and accessibility profile skewed towards the myeloid lineage rather than a stem cell programme [43] . Increased self-renewal and reduced responsiveness to differentiation-inducing signals may provide a selective advantage for cohesin mutations in AML. Although these landmark studies offer important insights into the role of cohesin in hematopoietic stem and progenitor cell(s) and AML, it remains unclear to what extent altered gene expression and chromatin accessibility are cause or consequence of increased self-renewal.
GENOME ORGANIZATION AND THE FREQUENCY OF RECURRENT TRANSLOCATIONS
Apart from changes in gene expression, threedimensional genome organization is linked to haematopoietic malignancies through chromosomal translocations. Translocations are key to lymphoid and other haematopoietic malignancies. Well known examples include a chromosomal translocation between the B cell receptor locus and the Abelson kinase locus translocations in CML and a chromosomal translocation between the promyelocytic leukemia locus and the retinoid receptor alpha locus translocations in promyelocytic leukaemia. The frequency with which translocations occur has been linked to the spatial proximity of the translocation partner genes [47] [48] [49] , which in turn is determined by cell-type-specific nuclear organization, for example through colocalization of actively transcribed genes [50] (Fig. 1c) .
Nuclear organization can not only facilitate, but also prevent translocations: in the fission yeast Schizosaccharomyces pombe, local genome organization by cohesin can prevent illegitimate recombination over large genomic distances, and in this way prevent genome instability [51] .
DNA fragility at loop anchors
Loop extrusion and chromatin dynamics within chromatin domains can result in torsional stress on DNA, for example in the form of DNA supercoils that propagate until they reach domain boundaries. DNA supercoiling domains are frequently flanked by CTCF [52] , and CTCF and cohesin colocalize at domain boundaries with type II topoisomerase (TOP2) [53] .
TOP2 releases torsional stress by cutting and religating DNA. TOP2 inhibitors such as etoposide (ETO) trap intermediate states of this reaction, prevent religaton and result in DNA double-strand breaks. In B cells, 70% of ETO-induced DNA-breaks overlapped CTCF peaks and 53% overlapped CTCFbased chromatin loops [7 & ]. Some of these sites correspond to breakpoint hotspots at frequently translocated oncogenes (Mll) and their recurrent fusion partners (Af9, Af4, Enl). Accordingly, chemotherapy with TOP2 inhibitors, such as epipodophyllotoxins or anthracyclines causes chromosomal translocations and secondary haematological neoplasias [54] .
Even in the absence of TOP2 inhibitors, biochemical assays detect an increased frequency of DNA breaks at topological domain boundaries [7 & ] (Fig. 1b) . What remains unclear is whether these breaks represent intermediate steps in the reaction by which TOP2 relieves torsional stress, or whether TOP2 has an intrinsic error rate high enough to promote translocations.
Super-enhancers are targets of the activation-induced cytidine deaminase AID
The majority of lymphomas are of B-cell origin, and most are derived from germinal centre or postgerminal centre stage cells [55] . In the germinal centre, antigen-activated B cells undergo somatic hypermutation by activation-induced cytidine deaminase (AID) and class-switch recombination of their immunoglobulin heavy chain genes. Although AID acts predominantly on immunoglobulin heavy chain genes, it often has off-target activity that can cause lesions at proto-oncogenes. This can result in carcinogenic translocations in which oncogene expression comes under the control of powerful, constitutively active regulatory elements of the immunoglobulin heavy chain locus, such as IGH-MYC or IGH-BCL6.
By mapping nascent transcription and DNA breaks in B cells, two studies have found that offtarget AID double-strand breaks are frequently located at super-enhancers [56, 57] . These clustered arrays of enhancers display high levels of mediator, transcription factor binding, enhancer RNA and drive the expression of cell-type-specific genes [58] . The presence of AID-induced double-strand breaks at these enhancers suggests that AID is attracted to chromatin states that resemble the native AID target, the immunoglobulin heavy chain locus.
Cohesin promotes connectivity between superenhancer constituents [59] , and is required for preventing self-association of active super-enhancers located on different chromosomes in trans [3 && ]. By counteracting the compartmentalization of super-enhancers cohesin may prevent the aggregation of AID off-target regions, and thereby reduce the probability of translocation events.
CONCLUSION
The formation of TADs by cohesin brings together sequences that lie between convergent CTCF sites. This facilitates physical interactions between enhancers and promoters located on the same domain, and reduces interactions with sequences outside the domain. During differentiation, CTCF provides a framework that enables cell-type-specific enhancer-promoter interactions. However, the acquisition of new interactions within domain boundaries is often determined by cell-type-specific factors. Chromatin state mixing by cohesin may facilitate chromatin state switches during differentiation. Therefore, cohesin may promote the ability to adopt new transcriptional programmes. Cohesindeficiency may provide a selective advantage to myeloid progenitors by desensitizing cells to differentiation cues, which can potentially explain the high frequency of cohesin mutations found in myeloid malignancies.
In contrast to myeloid leukaemia, frequent cohesin mutations have not been found in lymphoma. However, chromosomal translocations characteristic of lymphoma and lymphoid leukaemia are interrelated with the three-dimensional organization of the genome at different levels. Proximity between translocation partners is required, and it can be facilitated by short distances in the three-dimensional nucleus promoted by CTCF and cohesin. Translocations originate in DNA breaks, and DNA break formation by AID or Rag recombinases is dependent on transcription and threedimensional interactions. CTCF domain boundaries are regions of intense topoisomerase activity, and treatment with chemotherapeutic agents that block topoisomerase at intermediate steps can generate DNA damage and result in new translocations, leading to secondary leukaemia.
